Focus Stocks
High Above Average Volume on Novartis
Published on Friday, 17 August 2012 11:38 Written by TradersHuddle Wire
New York, August 17th (TradersHuddle.com) - Unusual high volume detected on shares of Novartis AG (NYSE:NVS) early in the trading session. The pace in volume of Novartis points to a break above average, with sellers in control, as the stock is 1.02% lower.
Novartis AG (NYSE:NVS) manufactures pharmaceutical and consumer healthcare products. The Company produces branded and generic pharmaceuticals for a number of uses like cardiovascular, respiratory and infectious diseases. The Basel, Switzerland based company also offers over the counter vision and animal health products.
Novartis has already traded 0.889 times its 3-month average volume and has calculated support and resistance at $55.10 and $59.55 respectively. Traders like to use volume as their lie detector for price action movement through predefined trading ranges.
The overall market index S&P 500 is trading flat by -0% from its previous trading close, which means that Novartis stock is underperforming the overall market.
Related Articles
- Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
- Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign
- Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign
Related Partner Headlines
- Novartis AG Stock Buy Recommendation Reiterated (NVS) - TheStreet.com
- Novartis AG Stock Buy Recommendation Reiterated (NVS) - TheStreet.com
- Novartis AG Stock Buy Recommendation Reiterated (NVS) - TheStreet.com
- Novartis Stock Hits New 52-Week High (NVS) - TheStreet.com
- Novartis AG Stock Buy Recommendation Reiterated (NVS) - TheStreet.com
- Novartis AG Stock Buy Recommendation Reiterated (NVS) - TheStreet.com
- Novartis Reaches New 52-Week High (NVS) - TheStreet.com
- Novartis AG Stock Buy Recommendation Reiterated (NVS) - TheStreet.com
- Novartis Stock Hits New 52-Week High (NVS) - TheStreet.com
- Novartis AG Stock Buy Recommendation Reiterated (NVS) - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,354.40 Trade time:4:40PM EDT Value change:▲121.18 (0.80%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,667.47 Trade time:4:39PM EDT Value change:▲17.00 (1.03%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,498.97 Trade time:5:15PM EDT Value change:▲33.73 (0.97%)In The Wires
-
Professionally Designed Wedding Dresses Now Online At Tidebuy.com -
DressFirst.com Is Providing Big Discounts On All Its Prom Dresses -
Great Discounts On Evening Dresses Announced by AmorModa.com -
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Vitamin Shoppe, Inc. To Contact The Firm -
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Ventrus Biosciences, Inc. To Contact The Firm -
Bruno Mars Ticket Prices Slashed at TicketProcess.com - Discounted Tickets Are Still Available With The Trusted Ticket Exchange Giant -
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Delcath Systems, Inc. To Contact The Firm -
The Rolling Stones Tour Tickets 2013 On Sale At TicketsTeam.com








